Life-science briefing: Thursday, March 13, 2008

TODAY’S HEADLINES:

Aperio Tech raises $20M for digital pathology (release)
TissueLink changes name, files for $86M IPO (Edgar)
Specialty pharma Cydex files to raise $50M in IPO (Edgar)
Hydra Biosciences takes in $34M for pain drugs (VentureWire)
AVI BioPharma acquires

Life-science briefing: Friday, March 7, 2008

TODAY’S HEADLINES:

Allegro pulls in $4M for lung-cancer molecular diagnostics (release)
Ocular bandage developer I-Therapeutix raises $6M (Mass High Tech)
NanoBio gets last of $30M for skin-infection drugs (release)
Cayenne Medical raises $15M for sports medicine (release)
Aridis Pharma seeks

Life sciences briefing: Wednesday, March 5, 2008

TODAY’S HEADLINES:

Precision Thera merger with “blank check” Oracle Healthcare collapses (release)
Sleep Solutions takes in $21M for sleep-apnea diagnostics (release)

Trevena takes in $24M for drugs targeting G-proteins (release)
“Specialty biotech” PanGenetics gets €23M for antibody drugs (release) Cancer-drug

Life sciences briefing: Monday, March 3 ,2008

TODAY’S HEADLINES:

InfraReDx takes $17M for arterial-plaque detection (VentureWire)
Cancer-drug developer Serenex sells out to Pfizer for undisclosed sum (release)
Life-sciences fund Longitude Capital raises $95M (VentureWire)
Hospital consultant Intercede Health names Gray Miller as CEO (release)

InfraReDx takes $17M 

Life sciences briefing: Thursday, Feb. 28, 2008

TODAY’S HEADLINES:

RNAi developer PhaseRx gets $4M of a pledged $19M (Seattle Times)
TyRx Pharma, drug-device combo maker, raises $25M (release)
Agennix aims at $40M for cancer drugs (VentureWire)
Starr Life Sciences goes after $1.6M for small-animal vital-signs scanner (VW)

Life sciences briefing: Tuesday, Feb. 26, 2008

TODAY’S HEADLINES:

Adnavance pulls in C$3.7M for molecular diagnostics, names new CEO (release)
“Personalized medicine” co. Proprius sells to Cypress Bio for up to $75M (release)
Vaccinex raises $25M in wake of GSK deal for antibody drugs (VentureWire)
Cianna Medical

Life sciences briefing: Friday, Feb. 22, 2008

TODAY’S HEADLINES:

HemCon Medical acquires Alltracel Pharma (release)
Transoma Medical, implantable wireless device maker, withdraws its IPO (Edgar)
Oracle Healthcare cuts Precision Thera acquisition price by roughly 15 percent (release)
MedBillManager adopts change:healthcare name, aims for March 3 relaunch release

Life sciences briefing: Thursday, Feb. 21, 2008

TODAY’S HEADLINES:

Compact ultrasound maker Zonare Medical raises $30M (VentureWire)
TherOx raises $30M for hypersaturated-oxygen devices (peHUB)
Accumetrics, antiplatelet-drug diagnostic maker, raises $29M (release)
Population Genetics takes in £3.8M for massively parallel genome studies (GenomeWeb)
“Brain fitness” trainer Dakim raises

Life sciences briefing: Tuesday, Feb. 19, 2008

TODAY’S HEADLINES

Sonoma Ortho names Glen Coleman as CEO, preps launch of bone implant (VentureWire)
TechniScan draws $13M for ultrasound CT scanners (release)
OrbiMed plans $150M Asian life-science fund (VentureWire)
Accelerated Tech pulls in $47M, aims for $125M in second

Life sciences briefing: Monday, Feb. 18, 2008

TODAY’S HEADLINES:

Sweden’s Elekta buys radiation-therapy software maker CMS for $75M (release)
Infusion-services firm Critical Homecare withdraws $125M IPO for buyout (Edgar)

NOTE: It’s a slow news day thanks to the President’s Day holiday. I’ll update with whatever else comes 

Life sciences briefing: Friday, Feb. 15, 2008

TODAY’S HEADLINES:

Q Thera takes in $15M for neural stem-cell treatments (release)
Stroke clotbuster Concentric Medical withdraws IPO (IPOhome)
Avera recaps with $9M to relaunch human tests of GI drug (VentureWire)
Tissue repairer Nerites raises $5.7M (release)
Semafore Pharma aims

Life sciences briefing: Thursday, Feb. 14, 2008

TODAY’S HEADLINES:

Arbor Surgical draws another $5.5M for heart-valve replacements (VBLS exclusive)
AstraZeneca spinout Albireo raises $27M for GI drugs (release)
Knee-implant maker MAKO Surgical slashes IPO price range (release)
eScreen takes in $8M for automated drug screening (peHUB) GlucoLight

Life sciences briefing: Monday, Feb. 11, 2008

TODAY’S HEADLINES:

PolyRemedy, developer of robotic wound care, takes in $25M (release)
Bacchus Vascular gets $15M for clot-busting device (VentureWire)
Protein-evolution company Modular Genetics gets $1.2M (VentureWire)
PharmatrophiX gets $300K for Alzheimer’s disease prevention drugs (release)
Light Sciences Oncology withdraws

Life sciences briefing: Friday, Feb. 8, 2008

TODAY’S HEADLINES:

AerovectRx takes $1.2M, looks for $5M more for inhaled drugs (VentureWire)
Pointe Conception, endoscopic camera maker, raises $800K (VentureWire)
Orion Healthcare aims for $250 million life-science fund (VentureWire)
Pennsylvania secures half of $10M Radius Venture fund for life

Life sciences briefing: Thursday, Feb. 7, 2008

TODAY’S HEADLINES:

Aptamer-drug maker Archemix withdraws its $72.5 million IPO (Edgar)
OraMetrix raises $20M for robotic orthodontic systems (peHUB)
Microarray maker TeleChem goes public via reverse merger (release)
BioVascular pulls in $11M for platelet-disease treatments (release)
Cequent Pharma adds $4.5M